Hamza Duygu

Hamza Duygu

Auto-generated profile, based on publicly available information

Hamza Duygu

Near East University Hospital, Department of Cardiology, Nicosia, Cyprus

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2008 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
HDHamza Duygu
Hamza Duygu
MZMehdi Zoghi
Mehdi Zoghi
UTUgur Turk
Ugur Turk
SASerdar Akyuz
Serdar Akyuz
FOFiliz Ozerkan
Filiz Ozerkan
MAMustafa Akin
Mustafa Akin

8 January 2008 in EP Europace
Verified
Journal Article
Open access
PDF file
HDHamza Duygu
Hamza Duygu
VBVatan Barisik
Vatan Barisik
HKHuseyin Kurt
Huseyin Kurt
UTUgur Turk
Ugur Turk
EEErtugrul Ercan
Ertugrul Ercan
SKSukran Kose
Sukran Kose
We aimed to clarify whether determination of levels of soluble CD40 ligand (sCD40L) could predict subsequent thrombo-embolic events in patients with non-valvular atrial fibrillation (NVAF). Forty-four consecutive outpatients (mean age: 58 ± 6 years, 20 male) with chronic NVAF who were not receiving aspirin and had no thrombus or spontaneous echo contrast (SEC) on left atrium (LA) or left atrial appendage (LAA) were included in the study. The patients had no history of an embolic event and were followed up 24 ± 2 months for thrombo-embolic events. sCD40L was determined at the enrollment. All patients were evaluated by means of SEC and thrombus formation by transoesophageal echocardiography at the end of follow-up period. Twelve (27%) patients had SEC and 2 (5%) patients had thrombus on LAA. Ischaemic stroke occurred in 2 (4.5%) patients and transient ischaemic attack developed in 4 (9%) patients during follow-up. sCD40L was significantly higher in patients with LASEC (0.41 ± 0.05 vs. 0.16 ± 0.04 ng/mL, P = 0.02) and embolic events (0.74 ± 0.05 vs. 0.19 ± 0.03 ng/mL, P = 0.001) than in those without. sCD40L levels were significantly related to the LASEC grade ( R = 0.377, P = 0.02). In multivariable analysis, while independent variables for SEC or thrombus formation were LA diameter, sCD40L levels, and the duration of AF, independent variables for cerebrovascular events were the existence of SEC or thrombus formation on LAA, and sCD40L level. Plasma sCD40L may prospectively predict stroke in AF. sCD40L may provide useful marker to identify patients at high thrombo-embolic risk with NVAF.

19 October 2007 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
HDH. Duygu
H. Duygu
FOF. Ozerkan
F. Ozerkan
MZM. Zoghi
M. Zoghi
SNS. Nalbantgil
S. Nalbantgil
AYA. Yildiz
A. Yildiz
OEO. Ergene
O. Ergene
Levosimendan is a novel positive inotropic calcium sensitiser agent used in acute left heart failure. In this study, the effect of levosimendan on the right ventricular systolic and diastolic functions was evaluated by tissue Doppler comparing them with dobutamine in patients with ischaemic heart failure. Patients having an acute decompensated heart failure with ischaemic cardiomyopathy and left ventricular ejection fraction <40% were included in the study. Before and 24-h after treatment, peak systolic (Sa), peak early (Ea), peak late (Aa) diastolic annular velocities and Ea/Aa ratio from tricuspid lateral annulus by tissue Doppler and systolic pulmonary artery pressure (SPAP) were measured. Sa, Ea and the Ea/Aa ratio were significantly increased in the levosimendan group whereas SPAP was significantly reduced. In the dobutamine group, no significant differences were observed in the Sa, Ea, Aa and Ea/Aa ratio in spite of a significant reduction in SPAP. Decrease in SPAP was greater in the levosimendan group (p=0.002). Levosimendan improves right ventricular systolic and diastolic functions.

26 July 2006 in Echocardiography
Verified
Journal Article
Closed access
PDF file
MZMehdi Zoghi
Mehdi Zoghi
HDHamza Duygu
Hamza Duygu
SNSanem Nalbantgil
Sanem Nalbantgil
BKBahadir Kirilmaz
Bahadir Kirilmaz
UTUgur Turk
Ugur Turk
CTCuneyt Turkoglu
Cuneyt Turkoglu

31 March 2008 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
HDHamza Duygu
Hamza Duygu
MZMehdi Zoghi
Mehdi Zoghi
SNSanem Nalbantgil
Sanem Nalbantgil
FOFiliz Ozerkan
Filiz Ozerkan
AAAzem Akilli
Azem Akilli
UEUmit Erturk
Umit Erturk

11 November 2008 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
MZMehdi Zoghi
Mehdi Zoghi
HDHamza Duygu
Hamza Duygu
HGHasan Gungor
Hasan Gungor
SNSanem Nalbantgil
Sanem Nalbantgil
FOFiliz Ozerkan
Filiz Ozerkan
MAMustafa Akin
Mustafa Akin